TAYSHA GENE THERAPIES INC (TSHA)
US8776191061 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 123.98M | 143.94M | 87.90M | 149.10M | 251.30M | |||
| Other Current Assets | 6.62M | 5.93M | 8.60M | 10.50M | 6.60M | |||
| Total Current Assets | 130.60M | 149.87M | 96.40M | 159.60M | 257.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 19.95M | 20.41M | 25.90M | 50.60M | 300.00K | |||
| Other Non-Current Assets | 2.46M | 2.46M | 4.00M | 3.70M | 700.00K | |||
| Total Non-Current Assets | 22.40M | 22.86M | 29.90M | 54.40M | 1.00M | |||
| TOTAL ASSETS | 153.00M | 172.73M | 126.30M | 214.00M | 258.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 362.00K | 354.00K | N/A | N/A | N/A | |||
| Accrued Expenses | 12.42M | 11.21M | 18.30M | 30.00M | 5.10M | |||
| Accounts Payable | 10.38M | 6.37M | 10.90M | 21.80M | 2.00M | |||
| Other Current Liabilities | 15.48M | 18.83M | 33.60M | N/A | N/A | |||
| Total Current Liabilities | 38.64M | 36.76M | 62.80M | 51.70M | 7.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 40.51M | 40.51M | 38.00M | 37.20M | 0.00 | |||
| Other Non-Current Liabilities | 20.00M | 20.53M | 24.60M | 29.60M | 500.00K | |||
| Total Non-Current Liabilities | 60.51M | 61.04M | 62.50M | 66.90M | 500.00K | |||
| TOTAL LIABILITIES | 99.15M | 97.79M | 125.30M | 118.60M | 7.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -537.07M | -513.01M | -401.40M | -235.60M | -61.10M | |||
| Additional Paid In Capital | 591.17M | 587.94M | 402.40M | 331.00M | 312.40M | |||
| Common Shares | 2.00K | 2.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -251.00K | N/A | N/A | 0.00 | 0.00 | |||
| Shares Outstanding | 187.02M | 186.96M | 63.20M | 38.50M | 34.50M | |||
| Tangible Book Value per Share | 0.29 | 0.40 | 0.01 | 2.48 | 7.28 | |||
| Total Shareholders' Equity | 53.85M | 74.94M | 900.00K | 95.40M | 251.30M | |||
| TOTAL LIABILITIES AND EQUITY | 153.00M | 172.73M | 126.30M | 214.00M | 258.90M | |||
| Statistics | ||||||||
| Debt/Equity | 0.75 | 0.54 | 42.22 | 0.39 | N/A | |||
| Current Ratio | 3.38 | 4.08 | 1.54 | 3.09 | 36.32 | |||
| Return On Assets (ROA) | -77.13% | -64.59% | -131.44% | -81.55% | -23.18% | |||
| Return On Equity (ROE) | -219.15% | -148.88% | -18445.56% | -182.94% | -23.88% | |||
All data in USD